|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/115 | |
| C12Q 1/68 | |||
| C07H 21/02 | |||
| C07H 21/04 | |||
| A61K 31/712 |
| (11) | Number of the document | 1727567 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05713496.7 |
| Date of filing the European patent application | 2005-02-14 | |
| (97) | Date of publication of the European application | 2006-12-06 |
| (45) | Date of publication and mention of the grant of the patent | 2013-07-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/004606 |
| Date | 2005-02-14 |
| (87) | Number | WO 2005/079363 |
| Date | 2005-09-01 |
| (30) | Number | Date | Country code |
| 544542 P | 2004-02-12 | US | |
| 547747 P | 2004-02-25 | US | |
| 581685 P | 2004-06-21 | US | |
| 608048 P | 2004-09-07 | US |
| (72) |
BENEDICT, Claude, US
DIENER, John, US
EPSTEIN, David, US
GRATE, Dilara, US
KEENE, Sara, Chesworth, US
KURZ, Jeffrey, US
KURZ, Markus, US
MCCAULEY, Thomas, Green, US
ROTTMAN, James, US
THOMPSON, Kristin, US
WILSON, Charles, US
ZOLTOSKI, Anna, J., US
|
| (73) |
Archemix LLC,
601 Montgomery Street, Suite 2020, San Francisco, CA 94111,
US
|
| (54) | Aptamer therapeutics useful in the treatment of complement-related disorders |
| Aptamer therapeutics useful in the treatment of complement-related disorders |